Eagle Genomics secures scale-up investment from OMRON Ventures

Eagle Genomics has secured scale-up funding from OMRON Ventures, adding to an ongoing investment round that previously drew capital from abrdn, Environmental Technologies Fund, and a consortium headed by Granpool Innovative Investments. The fresh injection of capital will support the continued development of the company's proprietary e[datascientist] platform. The funding also underpins wider global expansion efforts and aims to increase the company's client impact across various life sciences sectors.

OMRON Ventures joins an established group of backers supporting the Cambridge-headquartered platform provider. The ongoing financing cycle follows a first close secured in October 2022 led by abrdn. Eagle Genomics continues to expand its commercial footprint, partnering with major multinational brands to harness microbiome knowledge for sustainable product development and scientific discovery.